Peng-Hsu Chen

574 total citations
15 papers, 429 citations indexed

About

Peng-Hsu Chen is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Peng-Hsu Chen has authored 15 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Peng-Hsu Chen's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (5 papers). Peng-Hsu Chen is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (5 papers). Peng-Hsu Chen collaborates with scholars based in Taiwan and United States. Peng-Hsu Chen's co-authors include Ku‐Chung Chen, Kuo-Hao Ho, Chia‐Hsiung Cheng, Chwen-Ming Shih, Ann-Jeng Liu, Cheng‐Wei Lin, Yi‐Ting Lee, Chih‐Ming Chou, Chin-Cheng Lee and Chwen‐Ming Shih and has published in prestigious journals such as PLoS ONE, Scientific Reports and Life Sciences.

In The Last Decade

Peng-Hsu Chen

15 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng-Hsu Chen Taiwan 12 288 245 51 45 44 15 429
Kuo-Hao Ho Taiwan 14 326 1.1× 260 1.1× 52 1.0× 49 1.1× 54 1.2× 19 485
Ann-Jeng Liu Taiwan 14 302 1.0× 209 0.9× 78 1.5× 41 0.9× 37 0.8× 15 463
Wenbin Zhang China 10 348 1.2× 138 0.6× 50 1.0× 77 1.7× 35 0.8× 15 481
Qin Fang China 15 439 1.5× 160 0.7× 42 0.8× 46 1.0× 46 1.0× 37 547
Yanping Li China 11 254 0.9× 218 0.9× 26 0.5× 28 0.6× 50 1.1× 34 483
Karrie Mei Yee Kiang Hong Kong 9 199 0.7× 159 0.6× 58 1.1× 32 0.7× 25 0.6× 17 307
Dongmei Guo China 13 276 1.0× 106 0.4× 27 0.5× 20 0.4× 33 0.8× 35 409
Katarína Kľučková United Kingdom 11 334 1.2× 242 1.0× 37 0.7× 20 0.4× 54 1.2× 16 514
You Hwa Son South Korea 7 397 1.4× 355 1.4× 78 1.5× 26 0.6× 17 0.4× 10 580
Zi-Yuan Nie China 13 276 1.0× 140 0.6× 23 0.5× 20 0.4× 27 0.6× 19 373

Countries citing papers authored by Peng-Hsu Chen

Since Specialization
Citations

This map shows the geographic impact of Peng-Hsu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng-Hsu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng-Hsu Chen more than expected).

Fields of papers citing papers by Peng-Hsu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng-Hsu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng-Hsu Chen. The network helps show where Peng-Hsu Chen may publish in the future.

Co-authorship network of co-authors of Peng-Hsu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Peng-Hsu Chen. A scholar is included among the top collaborators of Peng-Hsu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng-Hsu Chen. Peng-Hsu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ho, Kuo-Hao, Peng-Hsu Chen, Chia‐Hsiung Cheng, et al.. (2024). Hypoxia enhances IL-8 signaling through inhibiting miR-128-3p expression in glioblastomas. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(2). 119885–119885. 1 indexed citations
3.
Ho, Kuo-Hao, Yi‐Ting Lee, Peng-Hsu Chen, et al.. (2021). Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling. Neurotherapeutics. 18(2). 1371–1392. 11 indexed citations
4.
Ho, Kuo-Hao, Peng-Hsu Chen, Chih‐Ming Chou, et al.. (2020). A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas. Neurotherapeutics. 17(3). 1212–1227. 36 indexed citations
5.
Ho, Kuo-Hao, Tai-Chih Kuo, Yi‐Ting Lee, et al.. (2020). Xanthohumol regulates miR-4749-5p-inhibited RFC2 signaling in enhancing temozolomide cytotoxicity to glioblastoma. Life Sciences. 254. 117807–117807. 26 indexed citations
6.
Ho, Kuo-Hao, Peng-Hsu Chen, Chwen-Ming Shih, et al.. (2020). miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas. Cellular and Molecular Neurobiology. 42(3). 791–806. 13 indexed citations
7.
Chen, Peng-Hsu, et al.. (2020). Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma. Taiwanese Journal of Obstetrics and Gynecology. 59(5). 698–705. 11 indexed citations
8.
Chen, Ku‐Chung, Peng-Hsu Chen, Kuo-Hao Ho, et al.. (2019). IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway. PLoS ONE. 14(12). e0225913–e0225913. 35 indexed citations
9.
Ho, Kuo-Hao, Chia‐Hsiung Cheng, Chih‐Ming Chou, et al.. (2019). miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Pharmacological Research. 147. 104390–104390. 38 indexed citations
10.
Chen, Peng-Hsu, Ann-Jeng Liu, Kuo-Hao Ho, et al.. (2018). microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells. Chemico-Biological Interactions. 291. 144–151. 34 indexed citations
11.
Ho, Kuo-Hao, Peng-Hsu Chen, Edward Hsi, et al.. (2017). Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis. Scientific Reports. 7(1). 30 indexed citations
12.
Chen, Peng-Hsu, Kuo-Hao Ho, Chwen-Ming Shih, et al.. (2017). The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA. PLoS ONE. 12(3). e0173890–e0173890. 13 indexed citations
13.
Chen, Peng-Hsu, Chia‐Hsiung Cheng, Chwen‐Ming Shih, et al.. (2016). The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. PLoS ONE. 11(11). e0167096–e0167096. 49 indexed citations
14.
Chen, Peng-Hsu, Cheng-Kuei Chang, Chwen-Ming Shih, et al.. (2016). The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death. Neuropharmacology. 110(Pt A). 362–375. 59 indexed citations
15.
Chen, Peng-Hsu, Chwen‐Ming Shih, Kuo-Hao Ho, et al.. (2016). The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity. Neuropharmacology. 116. 300–314. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026